Date:Monday, Nov. 13 - Thursday, Nov. 16, 2023 CET Location:Düsseldorf, Germany Official Website:https://www.medica-tradefair.com/ YINGCHI Booth:9C54 With over 5,000 exhibitors from 66 countries and more than 81,000 visitors from all over the world, MEDICA in Düsseldorf is one of the largest medical B2B trade fairs in the world. As an old friend, YINGCHI will once again participate in MEDICA 2023.... Read more
In September 2023, YINGCHI M-Ultimate TMS received FDA approval for the treatment of major depressive disorder in adult patients, marking a significant milestone in the company's endeavor to provide safe and effective medical solutions. Moreover, YINGCHI M-Ultimate TMS is not only limited to clinical applications; it is also playing an essential role in advancing clinical... Read more
We are glad to announce that YINGCHI M-Ultimate transcranial magnetic stimulator has already gained FDA approval this September . The M-Ultimate TMS is indicated for the treatment of Major Depressive Disorder in adult patients who have failed to receive satisfactory improvement from prior antidepressant medication in the current episode. Depression is a widespread and debilitating mental health condition,... Read more
Clinical Support Department of Shenzhen Yingchi Technology Co.,Ltd. Transcranial Magnetic Stimulation (TMS) is increasingly used to explore the neurophysiological mechanisms of neurodevelopmental and neurodegenerative diseases throughout the life cycle and to treat a range of neurological and psychiatric disorders in children, adults and the elderly. Different stimulation parameters and protocol types were used to explore... Read more
Clinical Support Department of Shenzhen Yingchi Technology Co.,Ltd. One of the most challenging clinical problems in the acute treatment of mood disorders: delayed response to treatment. First-line treatments such as medication and psychotherapy usually take several weeks to significantly improve symptoms. Numerous studies have shown that neuromodulatory strategies that act directly on neural circuits may... Read more
Clinical Support Department of Shenzhen Yingchi Technology Co.,Ltd. Peripartum Depression (PPD) is defined as the onset of depressive symptoms during pregnancy or within 12 months postpartum. PPD includes different types of depression depending on degree of severity and time of onset: prenatal depression, “baby blues” (feelings of sadness and tearfulness occurring after childbirth and usually resolving within... Read more
